Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-30T02:11:52.819Z Has data issue: false hasContentIssue false

8 - Gastric cancer: current trends and future opportunities

Published online by Cambridge University Press:  31 March 2010

By
Richard M. Gore ,
Huan Zhang ,
Chiao-Yun Chen  and
Kenjiro Yasuda
Edited by
Richard M. Gore
Richard M. Gore
Affiliation:
Northwestern University Medical School, Illinois
Get access

Summary

Introduction

Napoleon Bonaparte's remarkable political and military career was ended by Wellington at Waterloo in 1815. He died at age 52 on St. Helena in 1821 due to gastric cancer. Napoleon had a childhood of poverty, a poor diet in his early career, and a strong family history of gastric cancer, all of which contributed to his demise. It is now apparent that Helicobacter pylori, acting in the context of host genetic susceptibility, is responsible for most cases of stomach cancer. Napoleon was most likely infected with H. pylori – an example of the bacterium being mightier than the sword. This interaction between bacterium and host offers a new paradigm for carcinogenesis in the gastrointestinal (GI) tract and provides clues to the prevention and screening of this lethal malignancy.

As information concerning the epidemiology and molecular genetics of gastric cancer improves, sophisticated strategies for early detection and prevention of this disease in high-risk areas of the world will be developed. Eventually, molecular techniques will help identify those people at highest risk for this disease, so that resource-intensive endoscopic screening programs can be directed to this population. It is possible that, with directed use, screening programs will be validated by gastric cancer mortality reduction.

In this chapter, new concepts and horizons concerning prevention, screening, diagnosis, and treatment of patients with gastric adenocarcinoma are presented.

Type
Chapter
Information
Gastric Cancer , pp. 195 - 212
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

McKinlay, and El-Omar, EM. Adenocarcinoma (gastric cancer and miscellaneous malignancy). In Weinstein, WM, Hawkey, CJ, and Bosch, J eds., Clinical Gastroenterology and Hepatology. Philadelphia, PA: Elsevier-Mosby, 2005; pp. 233–42.Google Scholar
Waxman, I and Parmar, KS. Clinical aspects and management of gastric carcinoma: diagnostic and staging procedures. In Abbruzzese, JL, Evans, DB, Willett, CG, and Fenoglio-Preiser, C eds., Gastrointestinal Oncology. New York: Oxford University Press, 2004; pp. 294–301.Google Scholar
Stomach. In World Cancer Research Fund, American Institute for Cancer Research: Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington DC: The Institute, 1997; pp. 148–75.
Buiatti, E, Palli, D, Decarli, Aet al. A case-control study of gastric cancer and diet in Italy: II. Association with nutrients. Int J Cancer 1990; 45(5): 896–901.CrossRefGoogle ScholarPubMed
Blot, WJ, Li, JY, Taylor, PRet al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85(18): 1483–92.CrossRefGoogle ScholarPubMed
Plummer, M, Vivas, J, Lopez, Get al. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population. J Natl Cancer Inst 2007; 99(2): 137–46.CrossRefGoogle Scholar
Taylor, PR. Prevention of gastric cancer: a miss. J Natl Cancer Inst 2007; 99(2): 101–3.CrossRefGoogle ScholarPubMed
Malila, N, Taylor, PR, Virtanen, MJet al. Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland). Cancer Causes Control 2002; 13(7): 617–23.CrossRefGoogle Scholar
Correa, P, Fontham, ET, Bravo, JCet al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000; 92(23): 1881–8.CrossRefGoogle ScholarPubMed
Wong, BC, Lam, SK, Wong, WMet al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. J Am Med Assoc 2004; 291(2): 187–94.CrossRefGoogle Scholar
Nomura, A, Stemmermann, GN, Chyou, PHet al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325(16): 1132–6.CrossRefGoogle ScholarPubMed
Parsonnet, J, Friedman, GD, Vandersteen, DPet al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325(16): 1127–31.CrossRefGoogle ScholarPubMed
Forman, D, Newell, DG, Fullerton, Fet al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302(6788): 1302–5.CrossRefGoogle ScholarPubMed
Parsonnet, J, Harris, RA, Hack, HMet al. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996; 348(9021): 150–4.CrossRefGoogle ScholarPubMed
Miehlke, S, Kirsch, C, Dragosics, Bet al. Helicobacter pylori and gastric cancer: current status of the Austrian Czech German gastric cancer prevention trial (PRISMA Study). World J Gastroenterol 2001; 7(2): 243–7.CrossRefGoogle Scholar
Cheung, TK, Xia, HH, and Wong, BC. Helicobacter pylori eradication for gastric cancer prevention. J Gastroenterol 2007; 42 (Suppl 17): 10–15.CrossRefGoogle ScholarPubMed
Vries, AC, Haringsma, J, and Kuipers, EJ.The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007; 12(1): 1–15.CrossRefGoogle ScholarPubMed
Jessup, JM. Therapeutic principles of gastrointestinal neoplasia: emerging therapies: vaccines. In Abbruzzese, JL, Evans, DB, Willett, CG, and Fenoglio-Preiser, C eds., Gastrointestinal Oncology. New York: Oxford University Press, 2004; pp. 102–11.Google Scholar
Lee, Y-C, Lin, J-T, Chen, T, and Wu, M-S.Is eradication of Helicobacter pylori the feasible way to prevent gastric cancer? New evidence and progress, but still a long way to go. J Formos Med Assoc J 2008; 107: 591–9.CrossRefGoogle Scholar
Tahara, E. Molecular biology of gastric cancer. In Abbruzzese, JL, Evans, DB, Willett, CG, and Fenoglio-Preiser, C eds., Gastrointestinal Oncology. New York: Oxford University Press, 2004; pp. 268–80.Google Scholar
Hisamuchi, S, Fukao, P, Sugawara, Net al. Evaluation of mass screening programme for stomach cancer in Japan. In Miller, AB, Chamberlain, J, Day, NEet al. eds., Cancer Screening. Cambridge University Press, 1991; pp. 357–72.Google Scholar
Hamashima, C, Shibuya, D, Yamazaki, Het al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008; 38: 259–67.CrossRefGoogle ScholarPubMed
Kampschöer, GH, Fujii, A, and Masuda, Y. Gastric cancer detected by mass survey. Comparison between mass survey and outpatient detection. Scand J Gastroenterol 1989; 24(7): 813–17.CrossRefGoogle ScholarPubMed
Oshima, A, Hirata, N, Ubukata, Tet al. Evaluation of a mass screening program for stomach cancer with a case-control study design. Int J Cancer 1986; 38(6): 829–33.CrossRefGoogle ScholarPubMed
Hirayama, T, Hisamichi, S, Fujimoto, Iet al. Screening for gastric cancer. In Miller, AB ed., Screening for Cancer. New York: Academic Press, 1985; pp. 367–76.Google Scholar
Tytgat, GN, Mathus-Vliegen, EM, and Offerhaus, J. Value of endoscopy in the surveillance of high-risk groups for gastrointestinal cancer. In Sherlock, P, Morson, BC, Barbara, Let al. eds., Precancerous Lesions of the Gastrointestinal Tract. New York: Raven Press, 1983; pp. 305–18.Google Scholar
Inaba, S, Hirayama, H, Nagata, Cet al. Evaluation of a screening program on reduction of gastric cancer mortality in Japan: preliminary results from a cohort study. Prev Med 1999; 29(2): 102–6.Google ScholarPubMed
Mizoue, T, Yoshimura, T, Tokui, Net al. Prospective study of screening for stomach cancer in Japan. Int J Cancer 2003; 106(1): 103–7.CrossRefGoogle ScholarPubMed
Riecken, B, Pfeiffer, R, Ma, JLet al. No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk. Prev Med 2002; 34(1): 22–8.CrossRefGoogle Scholar
Pisani, P, Oliver, WE, Parkin, DMet al. Case-control study of gastric cancer screening in Venezuela. Br J Cancer 1994; 69(6): 1102–5.CrossRefGoogle ScholarPubMed
Kitahara, F, Kobayashi, K, Sato, Tet al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999; 44(5): 693–7.CrossRefGoogle ScholarPubMed
Staël, Holstein C, Eriksson, S, Huldt, Bet al. Endoscopic screening during 17 years for gastric stump carcinoma. A prospective clinical trial. Scand J Gastroenterol 1991; 26(10): 1020–6.Google Scholar
Ming, S and Goldman, H. Gastric polyps: a histogenetic classification and its relation to carcinoma. Cancer 1965; 18(6): 721–6.3.0.CO;2-0>CrossRefGoogle Scholar
Utsunomiya, J, Maki, T, Iwama, Tet al. Gastric lesion of familial polyposis coli. Cancer 1974; 34(3): 745–54.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Aarnio, M, Salovaara, R, Aaltonen, et al. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 1997; 74(5): 551–5.3.0.CO;2-9>CrossRefGoogle ScholarPubMed
Kurtz, RC and Sherlock, P. The diagnosis of gastric cancer. Semin Oncol 1985; 12(1): 11–18.Google Scholar
Brenner, H, Rothenbacher, D, and Arndt, V.Epidemiology of stomach cancer. Methods Mol Biol 2009; 472: 467–77.CrossRefGoogle ScholarPubMed
Moss, SF and Shirin, H. Epidemiology and molecular epidemiology of gastric cancer. In Abbruzzese, JL, Evans, DB, Willett, CG, and Fenoglio-Preiser, C eds., Gastrointestinal Oncology. New York: Oxford University Press, 2004; pp. 257–67.Google Scholar
Fareed, KR, Kaye, P, Soomro, INet al. Biomarkers of response to therapy in oesophago-gastric cancer. Gut 2009; 58(1): 127–43.CrossRefGoogle ScholarPubMed
Carneiro, F, Oliveira, C, Leite, M, and Seruca, R.Molecular targets and biological modifiers in gastric cancer. Semin Diagn Pathol 2008; 25(4): 274–87.CrossRefGoogle ScholarPubMed
Yasuda, K.Early gastric cancer: diagnosis, treatment techniques and outcomes. Eur J Gastroenterol Hepatol 2006; 18: 839–45.CrossRefGoogle ScholarPubMed
Testoni, PA.Optical coherence tomography. ScientificWorldJournal 2007; 7: 87–108.CrossRefGoogle ScholarPubMed
Xiong, H, Zeng, C, Guo, Zet al. Potential ability of hematoporphyrin to enhance an optical coherence tomographic image of gastric cancer in vivo in mice. Phys Med Biol 2008; 53(23): 6767–75.CrossRefGoogle Scholar
Yang, VX, Tang, SJ, Gordon, MLet al. Endoscopic Doppler optical coherence tomography in the human GI tract: initial experience. Gastrointest Endsoc 2005; 61(7): 879–90.CrossRefGoogle ScholarPubMed
Shen, B and Zuccaro, G.Optical coherence tomography in the gastrointestinal tract. Gastrointest Endosc Clin N Am 2004; 14: 555–71.CrossRefGoogle ScholarPubMed
Bouma, BE, Tearney, GJ, Comptom, CCet al. High-resolution imaging of the human esophagus and stomach in vivo using optical coherence tomography. Gastrointest Endosc 2000; 51: 467–74.CrossRefGoogle ScholarPubMed
Pfau, PR, Sivak, MV, Chak, Aet al. Criteria for the diagnosis of dysplasia by endoscopic coherence tomography. Gastrointest Endosc 2003; 58: 196–202.CrossRefGoogle Scholar
Zuccaro, G, Gladkova, N, Vargo, Jet al. Optical coherence tomography of the esophagus and proximal stomach in health and disease. Am J Gastroenterol 2001; 96: 2633–9.CrossRefGoogle ScholarPubMed
Tajima, Y, Yamazaki, K, Masuda, Yet al. Sentinel node mapping guided by indocyanine green fluorescence imaging in gastric cancer. Ann Surg 2009; 249: 58–62.CrossRefGoogle ScholarPubMed
Kusano, M, Tajima, Y, Yamazaki, Ket al. Sentinel node mapping guided by indocyanine green fluorescence imaging: a new method for sentinel node navigation surgery in gastrointestinal cancer. Dig Surg 2008; 25: 103–8.CrossRefGoogle ScholarPubMed
Miyashiro, I, Miyoshi, N, Hiratsuka, Met al. Detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging: comparison with infrared imaging. Ann Surg Oncol 2008; 15(6): 1640–3.CrossRefGoogle ScholarPubMed
Morita, D, Tsuda, H, Ichikura, Tet al. Analysis of sentinel node involvement in gastric cancer. Clin Gastroenterol Hepatol 2007; 5: 1046–52.CrossRefGoogle ScholarPubMed
Bergers, G and Benjamin, LE.Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3: 401–10.CrossRefGoogle ScholarPubMed
Fox, SB.Tumor angiogenesis and prognosis. Histopathology 1997; 30: 294–301.CrossRefGoogle ScholarPubMed
Miles, KA and Griffiths, MR.Perfusion CT: a worthwhile enhancement. Br J Radiol 2003; 76: 220–31.CrossRefGoogle ScholarPubMed
Kee, TY, Purdie, TG, and Stewart, E.CT imaging of angiogenesis. Q J Nucl Med 2003; 47: 171–87.Google Scholar
Sanelli, PC, Nicola, G, Tsiouris, AJet al. Reproducibility of postprocessing of quantitative CT perfusion maps. AJR Am J Roentgenol 2007; 188: 213–18.CrossRefGoogle ScholarPubMed
d'Assignies, G, Couvelard, A, Bahrami, Set al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 2009; 250: 407–16.CrossRefGoogle ScholarPubMed
Zhang, J, Pan, Z, Du, Let al. Advanced gastric cancer and perfusion imaging using multidetector row computed tomography: correlation with prognostic determinants. Korean J Radiol 2008; 9: 119–27.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×